A world where research conquers dementia.

Our vision

Our doors are open!

Will you help us transform dementia research?

Join us

We urge the closest possible cooperation between the UK and the EU after Brexit to preserve vital scientific research.

We are joining The Crick, and 29 Nobel prize winning scientists, in this call.
Our aim is to bring a solution for all dementias. This is by definition an international and long-term aim: we cannot tackle this problem in isolation.
The UK is a leader in the European science landscape but the current uncertainty around Brexit is already endangering this position. The prospect of a hard Brexit would dramatically affect the ability of the UK to attract and retain the brightest minds, seriously undermining the UK’s world leading role in scientific research and innovation, and ultimately impacting our ability to improve lives.

Let us know your thoughts
Dot Network Bg
Funding

D3A: Launching our new research accelerator partnership with DDF

We're delighted to join forces with The Dementia Discovery Fund to provide a series of awards, between £100,000 – £200,000, to support the translation of excellent science into the clinic.

The partnership
Connectome Group
Meetings

Connectome 2018

200 of our researchers gathered at our first annual retreat to share ideas and build connections.

Get a snapshot

Forward thinkers, step forward

The UK DRI focuses on innovative, early-stage science to advance our understanding of how dementias develop and progress. With hundreds of positions available, across all levels, see how you can be part of it and build your career at the UK DRI.

Join us
Dri Launch 175
Launch

Official opening: UK DRI at UCL

“This is the beginning of the end for dementia,” announced Prof Nick Fox, as we officially opened the hub of the institute at UCL, on 19 July 2018.

See what happened
Thinkstock Photos 840358600
News

Dementia is too big a problem to walk away from – for Pfizer or any of us

Our Director responds to Pfizer's decision to end their efforts in dementia drug discovery

Read more

Funders join forces to tackle dementia

The MRC, Alzheimer’s Society and Alzheimer’s Research UK have come together to invest £250 million in the new institute, to transform the outlook for people with dementia.

Meet the founders

Founding funders

Latest tweets from @UKDRI

RT @ImperialUKDRI: Welcome! @ImperialMed Prof Paul Matthews welcomes Giles Hardingham, #CityofEdinburgh Professor of Pharmacology; Associat…
14 Nov 2018 12:38

RT @ScienceofPD: Here comes the main event! Dr Arthur Roach is introducing the preliminary speaker Prof John Hardy @johnhardy1954 @UCLIoN
14 Nov 2018 10:36